Project Number 5P01AG014930-18 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Modulating Energy Metabolism as a Therapeutic Approach for Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator BEAL, M FLINT Principal Investigator First Name M FLINT Principal Investigator Last Name BEAL Awardee Organization WINIFRED MASTERSON BURKE MED RES INST Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-13-258: NIA Program Project Applications (P01) FY Overall Cost $505,100 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C Related Resources Repository [AlzPED] Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice. [AlzPED] Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s Disease
